Enveric Biosciences Inc [NASDAQ: ENVB] price plunged by -13.10 percent to reach at -$0.19.
A sum of 3647672 shares traded at recent session while its average daily volume was at 172.28K shares. Enveric Biosciences Inc shares reached a high of $1.45 and dropped to a low of $1.23 until finishing in the latest session at $1.26.
The one-year ENVB stock forecast points to a potential upside of 99.16. The average equity rating for ENVB stock is currently 1.00, trading closer to a bullish pattern in the stock market.
Guru’s Opinion on Enveric Biosciences Inc [ENVB]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ENVB shares is $150.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ENVB stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
The Price to Book ratio for the last quarter was 1.75, with the Price to Cash per share for the same quarter was set at 0.88.
ENVB Stock Performance Analysis:
Enveric Biosciences Inc [ENVB] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 8.45. With this latest performance, ENVB shares gained by 2.44% in over the last four-week period, additionally sinking by -40.57% over the last 6 months – not to mention a drop of -76.56% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ENVB stock in for the last two-week period is set at 52.53, with the RSI for the last a single of trading hit 0.1089, and the three-weeks RSI is set at 0.0915 for Enveric Biosciences Inc [ENVB]. The present Moving Average for the last 50 days of trading for this stock 1.2408, while it was recorded at 1.3158 for the last single week of trading, and 2.4701 for the last 200 days.
Enveric Biosciences Inc (ENVB) Capital Structure & Debt Analysis
According to recent financial data for Enveric Biosciences Inc. ( ENVB), the Return on Equity (ROE) stands at -261.96%, highlighting a negative impact on investor capital. The Return on Assets (ROA) is -207.14%, reflecting the company’s efficiency in generating profits from its assets. Additionally, Enveric Biosciences Inc’s Return on Invested Capital (ROIC) is -455.10%, showcasing its effectiveness in deploying capital for earnings.
Enveric Biosciences Inc (ENVB) Efficiency & Liquidity Metrics
Based on Enveric Biosciences Inc’s (ENVB) latest financial statements, the Debt-to-Equity Ratio is 0.00%, indicating its reliance on debt financing relative to shareholder equity.
Enveric Biosciences Inc (ENVB) Efficiency & Liquidity Metrics
From an operational efficiency perspective, Enveric Biosciences Inc. (ENVB) effectively leverages its workforce, generating an average of -$1988000.0 per employee. The company’s liquidity position is robust, with a Current Ratio of 2.43% and a Quick Ratio of 2.43%, indicating strong ability to cover short-term liabilities.
ENVB Stock EPS
With the latest financial reports released by the company, Enveric Biosciences Inc posted -9.15/share EPS, while the average EPS was predicted by analysts to be reported at -11.62/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 2.47. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for ENVB.
Enveric Biosciences Inc [ENVB] Institutonal Ownership Details
There are presently around $10.20%, or 10.95%% of ENVB stock, in the hands of institutional investors. The top three institutional holders of ENVB stocks are: ADVISORSHARES INVESTMENTS LLC with ownership of 0.32 million shares, which is approximately 7.9233%. GEODE CAPITAL MANAGEMENT, LLC, holding 44659.0 shares of the stock with an approximate value of $$27688.0 in ENVB stocks shares; and GEODE CAPITAL MANAGEMENT, LLC, currently with $$27268.0 in ENVB stock with ownership which is approximately 1.0886%.
